Abstract

The therapeutic landscape is experiencing a significant transformation with the development of strategies focused on the lysosomal degradation of extracellular targets. This innovative approach holds promise for combating many diseases by targeting and degrading pathogenic extracellular molecules. Pioneering advancements in this field introduce the concept of utilizing bifunctional compounds for the selective degradation of extracellular proteins and molecules. This Patent Highlight delves into the scientific principles, technological innovations, and therapeutic potential of these strategies, emphasizing their critical role in reshaping the future of medical treatments and highlighting their potential impact across a diverse range of disease contexts.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call